glp-1 shortage news today november 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 How GLP-1s Broke Healthcare Distribution

Theyre rolling out Yuify, their digital fortification for art integrity, straight into ibisPaint's hyper-mobile audience

Ozempic and Mounjaro can lower blood sugar levels overall

Brand-Name Alternatives Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are manufactured by pharmaceutical companies and distributed through traditional pharmacies, but their costs often exceed $900$1,400 per month even with insurance coverage

YM: Funding acquisition, Writing review & editing, Resources

These macules can go unnoticed for weeks or months before the contrast against the surrounding tissue becomes obvious enough to catch your attention

Detoxifies the body, improving skin clarity